Diagnosis and Treatment of Dermatomyositis

J Gordon Millichap

doi:10.15844/pedneurbriefs-20-7-2

Diagnosis and Treatment of Dermatomyositis

Pediatric Neurology Briefs

Volume 20 (2006): Issue 7

By: J Gordon Millichap

Open Access

|Jul 2006

Abstract

The impact of duration of untreated symptoms in children with juvenile dermatomyositis (JDM) on clinical and laboratory findings at diagnosis was studied in 166 patients enrolled in the National JDM Research Registry and examined at Children’s Memorial Hospital, Northwestern University; Loyola University; and University of Chicago, Chicago, IL; and other centers in the US.

References

Pachman LM Abbott K Sinacore JM Amoruso L Dyer A Lipton R Duration of illness is an important variable for untreated children with juvenile dermatomyositis J Pediatr 2006 Feb 148 2 247 253 10.1016/j.jpeds.2005.10.032 16492437
Open DOI Search in Google Scholar Back to article
Wohlgemuth M de Swart BJ Kalf JG Joosten FB Van der Vliet AM Padberg GW Dysphagia in facioscapulohumeral muscular dystrophy Neurology 2006 Jun 66 12 1926 1928 10.1212/01.wnl.0000219760.76441.f8 16801662
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-20-7-2 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 50 - 51

Published on: Jul 1, 2006

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Juvenile Dermatomyositis,

Serum Enzymes,

Dysphagia in Facioscapulohumeral Muscular Dystrophy

© 2006 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 20 (2006): Issue 7